Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples